You have /5 articles left.
Sign up for a free account or log in.
The Senate confirmed President Donald Trump’s pick to lead the National Institutes of Health on Tuesday.
Jay Bhattacharya, a Stanford University health economist who gained notoriety for his criticism of the NIH’s handling of the COVID-19 pandemic, secured the confirmation with a 53-to-47 party-line vote, The New York Times reported.
His confirmation as NIH director comes as the agency, which sends billions in funding each year to researchers at more than 2,500 universities, faces dramatic funding cuts and a shake-up of its research priorities. In the two months since Trump took office, the NIH has eliminated some 1,200 staff, effectively paused grant reviews and sent termination letters to many researchers whose NIH-funded projects allegedly conflict with Trump’s orders to eliminate support for diversity, equity and inclusion initiatives and other topics.
The NIH also issued guidance in February that would cap the funding it gives to universities for the indirect costs of research, such as building maintenance, hazardous waste removal and adhering to patient safety protocols. A federal judge blocked that guidance after numerous universities, research and higher education advocacy organizations, and 22 Democratic state attorneys general sued the NIH, arguing that the plan will hurt university budgets, local economies and the pace of scientific discovery.
At a confirmation hearing before the Senate Committee on Health, Education, Labor and Pensions earlier this month, Bhattacharya said that if confirmed, he would “fully commit to making sure that all the scientists at the NIH and the scientists that the NIH supports have the resources they need to meet the mission of the NIH.” However, he offered few specifics on how he’d do that and wouldn’t commit to axing the agency’s plan to cut indirect costs by more than $4 billion.
